Jia Kang, PhD (she/her/hers)

Principal Scientist II
Metrum Research Group, USA

Poster(s):

• (M-115) Dosage modifications in exposure-response analyses of oncology drug development: the brigimadlin case study
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT